3749-38-0Relevant articles and documents
Siroxylin derivative and application thereof
-
Paragraph 0034-0039, (2021/05/08)
The invention provides a daphnoretin derivative and application thereof. The daphnoretin derivative or a stereoisomer, hydrate, ester, solvate, eutectic, metabolite and pharmaceutically accepted saltor prodrug of the daphnoretin derivative has good anti-tumor activity, the anti-tumor activity of the daphnoretin derivative is obviously better than that of daphnoretin, and the daphnoretin derivative can be used as a novel efficient low-toxicity anti-tumor drug.